Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden (original) (raw)

Molecular Psychiatry volume 9, pages 547–549 (2004)Cite this article

SIR – The addictions are complex diseases whose onset, persistence, and treatment are influenced by interactions between genetic, environmental, and pharmacological factors.1 A study of 3372 twin pairs found that genetic, shared environmental, and nonshared environmental factors similarly influence the development of drug abuse and dependence.2 The authors also found that 54% of the total and 38% of the unique variance in heroin abuse were attributable to genetic factors.2

Mu-opioid receptor (OPRM1) gene polymorphisms are logical candidates for association studies in the addictive diseases.3 The endogenous opioid system is central to the function and modulation of physiological systems affected by all drugs of abuse.1 Quantitative trait locus studies and studies in OPRM1 knockout mice have confirmed the importance of this receptor to the rewarding effects of opiates and other drugs of abuse.4,5,6

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Kreek MJ et al. Nat Rev Drug Disc 2002; 1: 710–726.
  2. Tsuang MT et al. Arch Gen Psychiatry 1998; 55: 967–972.
    Article CAS Google Scholar
  3. LaForge KS et al. Eur J Pharmacol 2000; 410(2): 249–268.
  4. Belknap JK et al. Ann NY Acad Sci 1992; 645: 311–323.
  5. Matthes HWD et al. Nature 1996; 383: 819–823.
    Article CAS Google Scholar
  6. Becker A et al. Naunym-Schmiedebergs Arch Pharmacol 2000; 361: 584–589.
  7. Bond C et al. Proc Natl Acad Sci USA 1998; 95: 9608–9613.
  8. Wand GS et al. Neuropsychopharmacology 2002; 26: 106–114.
    Article CAS Google Scholar
  9. Hernandez-Avila CA et al. Am J Med Genet 2003; 118B: 60–65.
  10. Oslin DW et al. Neuropsychopharmacology 2003; 28: 1546–1552.
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA
    G Bart, K S LaForge & M J Kreek
  2. Division of Psychiatry, NEUROTEC, Karolinska Institute, M57 Huddinge University Hospital, Stockholm, Sweden
    M Heilig, L Pollak & M J Kreek
  3. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA
    S M Leal
  4. The Laboratory of Statistical Genetics, The Rockefeller University, New York, NY, USA
    J Ott

Authors

  1. G Bart
  2. M Heilig
  3. K S LaForge
  4. L Pollak
  5. S M Leal
  6. J Ott
  7. M J Kreek

Corresponding author

Correspondence toG Bart.

Rights and permissions

About this article

Cite this article

Bart, G., Heilig, M., LaForge, K. et al. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden.Mol Psychiatry 9, 547–549 (2004). https://doi.org/10.1038/sj.mp.4001504

Download citation

This article is cited by